WallStreetZenWallStreetZen

NASDAQ: RZLT
Rezolute Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for RZLT

Based on 5 analysts offering 12 month price targets for Rezolute Inc.
Min Forecast
$9.00+218.02%
Avg Forecast
$14.40+408.83%
Max Forecast
$18.00+536.04%

Should I buy or sell RZLT stock?

Based on 5 analysts offering ratings for Rezolute Inc.
Strong Buy
Strong Buy
4 analysts 80%
Buy
1 analysts 20%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their RZLT stock forecasts and price targets.

RZLT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Jefferies
Bottom 13%
13
Strong BuyInitiates Coverage On$11.00+288.69%2022-09-12
Canaccord Genuity
Top 21%
80
Strong BuyAssumes$17.00+500.71%2022-08-02
Cantor Fitzgerald
Top 49%
52
Strong BuyInitiates Coverage On$9.00+218.02%2022-06-15
Canaccord Genuity
Bottom 3%
3
Strong BuyMaintains$17.00+500.71%2021-11-29
JMP Securities
Bottom 8%
8
BuyMaintains$18.00+536.04%2021-11-15

1 of 1

Forecast return on equity

Is RZLT forecast to generate an efficient return?
Company
-68.06%
Industry
22.46%
Market
122.06%
RZLT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is RZLT forecast to generate an efficient return on assets?
Company
-66.74%
Industry
13.57%
RZLT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

RZLT earnings per share forecast

What is RZLT's earnings per share in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$2.07
Avg 2 year Forecast
-$2.72
Avg 3 year Forecast
-$2.62

RZLT revenue forecast

What is RZLT's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$5.0M
Avg 2 year Forecast
$18.4M
Avg 3 year Forecast
$131.4M

RZLT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
RZLT$2.83$14.40+408.83%Strong Buy
PRTG$6.48$22.00+239.51%Buy
IMUX$3.61$27.25+654.85%Strong Buy
SLGL$4.72$19.00+302.54%Strong Buy
ANVS$13.37$38.50+187.96%Strong Buy

Rezolute Stock Forecast FAQ

Is Rezolute Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: RZLT) stock is to Strong Buy RZLT stock.

Out of 5 analysts, 4 (80%) are recommending RZLT as a Strong Buy, 1 (20%) are recommending RZLT as a Buy, 0 (0%) are recommending RZLT as a Hold, 0 (0%) are recommending RZLT as a Sell, and 0 (0%) are recommending RZLT as a Strong Sell.

If you're new to stock investing, here's how to buy Rezolute stock.

What is RZLT's earnings growth forecast for 2023-2025?

(NASDAQ: RZLT) Rezolute's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 8.86%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 16.88%.

Rezolute's earnings in 2022 is -$41,060,000.On average, 2 Wall Street analysts forecast RZLT's earnings for 2023 to be -$80,373,064, with the lowest RZLT earnings forecast at -$84,255,820, and the highest RZLT earnings forecast at -$76,490,307. On average, 1 Wall Street analyst forecast RZLT's earnings for 2024 to be -$105,610,982, with the lowest RZLT earnings forecast at -$105,610,982, and the highest RZLT earnings forecast at -$105,610,982.

In 2025, RZLT is forecast to generate -$101,728,226 in earnings, with the lowest earnings forecast at -$101,728,226 and the highest earnings forecast at -$101,728,226.

What is RZLT's revenue growth forecast for 2024-2026?

(NASDAQ: RZLT) Rezolute's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 23.83%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.53%.

Rezolute's revenue in 2022 is $0.On average, 1 Wall Street analysts forecast RZLT's revenue for 2024 to be $195,690,938, with the lowest RZLT revenue forecast at $195,690,938, and the highest RZLT revenue forecast at $195,690,938. On average, 1 Wall Street analysts forecast RZLT's revenue for 2025 to be $712,874,130, with the lowest RZLT revenue forecast at $712,874,130, and the highest RZLT revenue forecast at $712,874,130.

In 2026, RZLT is forecast to generate $5,100,389,201 in revenue, with the lowest revenue forecast at $5,100,389,201 and the highest revenue forecast at $5,100,389,201.

What is RZLT's forecast return on assets (ROA) for 2023-2025?

(NASDAQ: RZLT) forecast ROA is -66.74%, which is lower than the forecast US Biotechnology industry average of 13.57%.

What is RZLT's Price Target?

According to 5 Wall Street analysts that have issued a 1 year RZLT price target, the average RZLT price target is $14.40, with the highest RZLT stock price forecast at $18.00 and the lowest RZLT stock price forecast at $9.00.

On average, Wall Street analysts predict that Rezolute's share price could reach $14.40 by Sep 12, 2023. The average Rezolute stock price prediction forecasts a potential upside of 408.83% from the current RZLT share price of $2.83.

What is RZLT's Earnings Per Share (EPS) forecast for 2023-2025?

(NASDAQ: RZLT) Rezolute's current Earnings Per Share (EPS) is -$2.26. On average, analysts forecast that RZLT's EPS will be -$2.07 for 2023, with the lowest EPS forecast at -$2.17, and the highest EPS forecast at -$1.97. On average, analysts forecast that RZLT's EPS will be -$2.72 for 2024, with the lowest EPS forecast at -$2.72, and the highest EPS forecast at -$2.72. In 2025, RZLT's EPS is forecast to hit -$2.62 (min: -$2.62, max: -$2.62).

What is RZLT's forecast return on equity (ROE) for 2023-2025?

(NASDAQ: RZLT) forecast ROE is -68.06%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.